Literature DB >> 19782004

SCN1A mutation screening in adult patients with Lennox-Gastaut syndrome features.

Kaja Kristine Selmer1, Caroline Lund, Kristin Brandal, Dag Erik Undlien, Eylert Brodtkorb.   

Abstract

Mutations in the SCN1A gene have been identified in a variety of epilepsy phenotypes, from severe encephalopathies such as Dravet syndrome to milder familial forms such as generalized epilepsy with febrile seizures plus. In a previous study, an SCN1A mutation was also identified in a patient with Lennox-Gastaut syndrome (LGS), and the aim of our study was to investigate the importance of mutations in the SCN1A gene in Norwegian patients with clinical features of LGS. We screened 22 adult patients for SCN1A mutations by direct sequencing of DNA and for micro-rearrangements with multiplex ligation-dependent probe amplification. In one patient a mutation was found, which demonstrates a clinical overlap between LGS and Dravet syndrome. This finding emphasizes the significance of SCN1A mutations also in epileptic disorders with features of LGS, particularly in the myoclonic variant of the disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782004     DOI: 10.1016/j.yebeh.2009.08.021

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  9 in total

1.  Nav1.1 modulation by a novel triazole compound attenuates epileptic seizures in rodents.

Authors:  John Gilchrist; Stacey Dutton; Marcelo Diaz-Bustamante; Annie McPherson; Nicolas Olivares; Jeet Kalia; Andrew Escayg; Frank Bosmans
Journal:  ACS Chem Biol       Date:  2014-03-31       Impact factor: 5.100

Review 2.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

Review 3.  Lennox-Gastaut syndrome. Management update.

Authors:  Muradi H Al-Banji; Doaa K Zahr; Mohammed M Jan
Journal:  Neurosciences (Riyadh)       Date:  2015-07       Impact factor: 0.906

4.  A Study among the Genotype, Functional Alternations, and Phenotype of 9 SCN1A Mutations in Epilepsy Patients.

Authors:  Daniela Kluckova; Miriam Kolnikova; Lubica Lacinova; Bohumila Jurkovicova-Tarabova; Tomas Foltan; Viktor Demko; Ludevit Kadasi; Andrej Ficek; Andrea Soltysova
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

5.  A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.

Authors:  Christopher J Perry; Paul Finch; Annette Müller-Taubenberger; Kit-Yi Leung; Eleanor C Warren; Joseph Damstra-Oddy; Devdutt Sharma; Pabitra H Patra; Sarah Glyn; Joanna Boberska; Balint Stewart; Amy Baldwin; Fabiana Piscitelli; Robert J Harvey; Adrian Harwood; Christopher Thompson; Sandrine P Claus; Nicholas D E Greene; Alister J McNeish; Claire M Williams; Benjamin J Whalley; Robin S B Williams
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

Review 6.  SCN1A Mutation-Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis.

Authors:  Jiangwei Ding; Xinxiao Li; Haiyan Tian; Lei Wang; Baorui Guo; Yangyang Wang; Wenchao Li; Feng Wang; Tao Sun
Journal:  Front Neurol       Date:  2021-12-24       Impact factor: 4.003

7.  Clinical and Functional Features of Epilepsy-Associated In-Frame Deletion Variants in SCN1A.

Authors:  Jing-Yang Wang; Bin Tang; Wen-Xiang Sheng; Li-Dong Hua; Yang Zeng; Cui-Xia Fan; Wei-Yi Deng; Mei-Mei Gao; Wei-Wen Zhu; Na He; Tao Su
Journal:  Front Mol Neurosci       Date:  2022-03-14       Impact factor: 5.639

8.  Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes.

Authors:  Jiangwei Ding; Lei Wang; Zhe Jin; Yuanyuan Qiang; Wenchao Li; Yangyang Wang; Changliang Zhu; Shucai Jiang; Lifei Xiao; Xiaoyan Hao; Xulei Hu; Xinxiao Li; Feng Wang; Tao Sun
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

Review 9.  Common Ribs of Inhibitory Synaptic Dysfunction in the Umbrella of Neurodevelopmental Disorders.

Authors:  Rachel Ali Rodriguez; Christina Joya; Rochelle M Hines
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.